239 related articles for article (PubMed ID: 30717974)
1. Proton pumping V-ATPase inhibitor bafilomycin A1 affects Rab7 lysosomal localization and abolishes anterograde trafficking of osteoclast secretory lysosomes.
Matsumoto N; Nakanishi-Matsui M
Biochem Biophys Res Commun; 2019 Mar; 510(3):421-426. PubMed ID: 30717974
[TBL] [Abstract][Full Text] [Related]
2. The lysosomal V-ATPase a3 subunit is involved in localization of Mon1-Ccz1, the GEF for Rab7, to secretory lysosomes in osteoclasts.
Matsumoto N; Sekiya M; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
Sci Rep; 2022 May; 12(1):8455. PubMed ID: 35589873
[TBL] [Abstract][Full Text] [Related]
3. V-ATPase a3 Subunit in Secretory Lysosome Trafficking in Osteoclasts.
Nakanishi-Matsui M; Matsumoto N
Biol Pharm Bull; 2022; 45(10):1426-1431. PubMed ID: 36184499
[TBL] [Abstract][Full Text] [Related]
4. Role of the Cytosolic Domain of the a3 Subunit of V-ATPase in the Interaction with Rab7 and Secretory Lysosome Trafficking in Osteoclasts.
Nakanishi-Matsui M; Matsumoto N; Sun-Wada GH; Wada Y
Biol Pharm Bull; 2024; 47(1):339-344. PubMed ID: 38296463
[TBL] [Abstract][Full Text] [Related]
5. Essential Role of the a3 Isoform of V-ATPase in Secretory Lysosome Trafficking via Rab7 Recruitment.
Matsumoto N; Sekiya M; Tohyama K; Ishiyama-Matsuura E; Sun-Wada GH; Wada Y; Futai M; Nakanishi-Matsui M
Sci Rep; 2018 Apr; 8(1):6701. PubMed ID: 29712939
[TBL] [Abstract][Full Text] [Related]
6. Functional complementation of V-ATPase a subunit isoforms in osteoclasts.
Matsumoto N; Sekiya M; Fujimoto Y; Haga S; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
J Biochem; 2021 Apr; 169(4):459-466. PubMed ID: 33135054
[TBL] [Abstract][Full Text] [Related]
7. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
Niikura K; Takano M; Sawada M
Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
[TBL] [Abstract][Full Text] [Related]
8. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
Nyman JK; Väänänen HK
Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
[TBL] [Abstract][Full Text] [Related]
9. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
Sahara T; Itoh K; Debari K; Sasaki T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
[TBL] [Abstract][Full Text] [Related]
10. V-ATPase a3 isoform mutations identified in osteopetrosis patients abolish its expression and disrupt osteoclast function.
Matsumoto N; Matsukawa R; Takahashi S; Kudo K; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
Exp Cell Res; 2020 Apr; 389(2):111901. PubMed ID: 32045577
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
[TBL] [Abstract][Full Text] [Related]
12. From lysosomes to the plasma membrane: localization of vacuolar-type H+ -ATPase with the a3 isoform during osteoclast differentiation.
Toyomura T; Murata Y; Yamamoto A; Oka T; Sun-Wada GH; Wada Y; Futai M
J Biol Chem; 2003 Jun; 278(24):22023-30. PubMed ID: 12672822
[TBL] [Abstract][Full Text] [Related]
13. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
[TBL] [Abstract][Full Text] [Related]
14. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
[TBL] [Abstract][Full Text] [Related]
15. Roles for H
Lee H; Koh JY
Glia; 2021 May; 69(5):1110-1125. PubMed ID: 33314298
[TBL] [Abstract][Full Text] [Related]
16. Vacuolar-type ATPase: A proton pump to lysosomal trafficking.
Futai M; Sun-Wada GH; Wada Y; Matsumoto N; Nakanishi-Matsui M
Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(6):261-277. PubMed ID: 31189779
[TBL] [Abstract][Full Text] [Related]
17. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
Mattsson JP; Keeling DJ
Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
[TBL] [Abstract][Full Text] [Related]
18. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
Niikura K; Takeshita N; Takano M
J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
[TBL] [Abstract][Full Text] [Related]
19. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion.
Mauvezin C; Neufeld TP
Autophagy; 2015; 11(8):1437-8. PubMed ID: 26156798
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway proteins.
Sobota JA; Bäck N; Eipper BA; Mains RE
J Cell Sci; 2009 Oct; 122(Pt 19):3542-53. PubMed ID: 19737820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
